{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:45:56Z","timestamp":1792838756314,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n            <jats:title>Background and Aims<\/jats:title>\n            <jats:p>Type 2 diabetes is an important risk factor for nonalcoholic fatty liver disease (NAFLD) and advanced fibrosis. Current international guidelines recommend the use of noninvasive tests as initial assessments for NAFLD, but the role of noninvasive tests as monitoring tools has not been established. We aimed to study the role of transient elastography as a monitoring tool in patients with type 2 diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Approach and Results<\/jats:title>\n            <jats:p>We recruited patients with type 2 diabetes without viral hepatitis or excessive alcohol intake from a complication screening facility in Hong Kong in 2013\u20102014 and repeated the assessments in 2016\u20102018. The primary endpoint was an increase of liver stiffness measurement (LSM) to \u226510\u00a0kPa. The secondary endpoint was the change in the controlled attenuation parameter (CAP). A total of 611 patients with type 2 diabetes and a valid LSM (mean age, 57.7\u00a0\u00b1\u00a010.9\u00a0years; 342 men [56.0%]) were included in this study (568 also had a valid CAP). Overall, there was moderate correlation between the baseline and follow\u2010up LSM (<jats:italic toggle=\"yes\">r<\/jats:italic>\u00a0=\u00a00.689, <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0&lt;\u00a00.001). Among 487 patients with a baseline LSM &lt;10\u00a0kPa, 21 (4.3%) had a follow\u2010up LSM \u226510\u00a0kPa. Baseline body mass index, alanine aminotransferase (ALT), and \u2206ALT were independent factors associated with LSM increase. Among 124 patients with a baseline LSM \u226510\u00a0kPa, 70 (56.5%) had a follow\u2010up LSM &lt;10\u00a0kPa. Among 198 patients with a CAP &lt;248\u00a0dB\/m at baseline, 103 (52.0%) had a CAP increased to \u2265248\u00a0dB\/m.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The prevalence and incidence of NAFLD in patients with type 2 diabetes are high. Although advanced fibrosis is common in this population, few patients progress to advanced fibrosis in 3\u00a0years. Future studies should define the optimal surveillance interval in patients with diabetes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.31142","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:19:59Z","timestamp":1580257199000},"page":"1230-1241","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":79,"title":["Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study"],"prefix":"10.1097","volume":"72","author":[{"given":"Hye Won","family":"Lee","sequence":"first","affiliation":[{"name":"Institute of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Department of Internal Medicine,College of Medicine, Yonsei University,Seoul,South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-9389","authenticated-orcid":false,"given":"Grace Lai\u2010Hung","family":"Wong","sequence":"additional","affiliation":[{"name":"Institute of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Kwok","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology,Blacktown Hospital,Sydney,Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Chow","family":"Choi","sequence":"additional","affiliation":[{"name":"Nethersole School of Nursing,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Ka\u2010Man","family":"Chan","sequence":"additional","affiliation":[{"name":"Institute of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally She\u2010Ting","family":"Shu","sequence":"additional","affiliation":[{"name":"Institute of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Ka\u2010Yu","family":"Leung","sequence":"additional","affiliation":[{"name":"Institute of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel Mei\u2010Ling","family":"Chim","sequence":"additional","affiliation":[{"name":"Institute of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea On\u2010Yan","family":"Luk","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Hong Kong Institute of Diabetes and Obesity,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Li Ka Shing Institute of Health Science,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Ching\u2010Wan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Hong Kong Institute of Diabetes and Obesity,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Li Ka Shing Institute of Health Science,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Lik\u2010Yuen","family":"Chan","sequence":"additional","affiliation":[{"name":"Institute of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Chung\u2010Ngor","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Hong Kong Institute of Diabetes and Obesity,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Li Ka Shing Institute of Health Science,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Pik\u2010Shan","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Hong Kong Institute of Diabetes and Obesity,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Li Ka Shing Institute of Health Science,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-9410","authenticated-orcid":false,"given":"Vincent Wai\u2010Sun","family":"Wong","sequence":"additional","affiliation":[{"name":"Institute of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong Special Administrative Region,China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"hep31142-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","year":"2019","journal-title":"Hepatology"},{"key":"hep31142-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31142-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(16)30011-5","article-title":"Pathogenesis and novel treatment options for non\u2010alcoholic steatohepatitis","volume":"1","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"hep31142-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/apt.15015","article-title":"The effects of metabolic status on non\u2010alcoholic fatty liver disease\u2010related outcomes, beyond the presence of obesity","volume":"48","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31142-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause\u2010specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi\u2010national cohort study","volume":"155","year":"2018","journal-title":"Gastroenterology"},{"key":"hep31142-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1365-2036.2006.03112.x","article-title":"Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non\u2010alcoholic fatty liver disease","volume":"24","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31142-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"hep31142-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL\u2010EASD\u2010EASO Clinical Practice Guidelines for the management of non\u2010alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"hep31142-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia\u2010Pacific working party on non\u2010alcoholic fatty liver disease guidelines 2017\u2010part 1: definition, risk factors and assessment","volume":"33","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31142-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH\u2014current progress and future promise","volume":"15","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"hep31142-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non\u2010alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study","volume":"65","year":"2016","journal-title":"Gut"},{"key":"hep31142-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","article-title":"Disease progression of non\u2010alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years","volume":"59","year":"2010","journal-title":"Gut"},{"key":"hep31142-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta\u2010analysis of paired\u2010biopsy studies","volume":"13","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31142-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"hep31142-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/ajg.2012.331","article-title":"Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease","volume":"107","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"hep31142-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"hep31142-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1136\/gutjnl-2018-317334","article-title":"Unified interpretation of liver stiffness measurement by M and XL probes in non\u2010alcoholic fatty liver disease","volume":"68","year":"2019","journal-title":"Gut"},{"key":"hep31142-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta\u2010analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"hep31142-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3851\/IMP1726","article-title":"On\u2010treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients","volume":"16","year":"2011","journal-title":"Antivir Ther"},{"key":"hep31142-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MCG.0000000000000099","article-title":"Double\u2010blind randomized placebo\u2010controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis","volume":"49","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"hep31142-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo\u2010controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"hep31142-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing\u2010steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","year":"2015","journal-title":"J Hepatol"},{"key":"hep31142-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2016.04.023","article-title":"Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non\u2010alcoholic fatty liver disease","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"hep31142-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jgh.14311","article-title":"Repeating measurements by transient elastography in non\u2010alcoholic fatty liver disease patients with high liver stiffness","volume":"34","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31142-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/jgh.13671","article-title":"Application of the combined FibroMeter vibration\u2010controlled transient elastography algorithm in Chinese patients with non\u2010alcoholic fatty liver disease","volume":"32","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31142-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.cgh.2019.03.006","article-title":"Optimizing use of nonalcoholic fatty liver disease fibrosis score, fibrosis\u20104 score, and liver stiffness measurement to identify patients with advanced fibrosis","volume":"17","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31142-bib-0028-20241017","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1440-1746.2010.06528.x","article-title":"Postprandial hyperinsulinemia is universal in non\u2010diabetic patients with nonalcoholic fatty liver disease","volume":"26","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31142-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease\u2010specific mortality in NAFLD after up to 33 years of follow\u2010up","volume":"61","year":"2015","journal-title":"Hepatology"},{"key":"hep31142-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/ajg.2017.389","article-title":"Prognostic value of controlled attenuation parameter by transient elastography","volume":"112","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"hep31142-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jhep.2017.05.005","article-title":"Validity criteria for the diagnosis of fatty liver by M probe\u2010based controlled attenuation parameter","volume":"67","year":"2017","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.31142","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.31142","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.31142","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.31142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T23:26:24Z","timestamp":1729207584000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.31142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.31142","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"2019-07-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}